60 related articles for article (PubMed ID: 23628821)
1. EGFR promoter methylation detection in cervical cancer by a hybridization-fluorescence polarization assay.
Zhang W; Gao Y; Jiang Y; Ping L; Cheng H; Zhang J
Diagn Mol Pathol; 2013 Jun; 22(2):102-6. PubMed ID: 23628821
[TBL] [Abstract][Full Text] [Related]
2. O⁶-Methylguanine-DNA methyltransferase gene promoter methylation detection in glioma tumors by a novel fluorescence polarization assay.
Wu Z; Zhang J; Cheng H; Liang P; Guo Y; Yan Z; Zhao J
Diagn Mol Pathol; 2010 Dec; 19(4):232-5. PubMed ID: 21051997
[TBL] [Abstract][Full Text] [Related]
3. Detection of p16INK4a promoter methylation status in non-small cell lung cancer by a fluorescence polarization assay.
Song Z; Zhou R; Li D; Chen Y; Liang P; Liu W; Zhang J
Diagn Mol Pathol; 2011 Sep; 20(3):138-42. PubMed ID: 21817906
[TBL] [Abstract][Full Text] [Related]
4. Detection of EGFR mutation in tissue samples of non-small-cell lung cancer by a fluorescence polarization assay.
Liu W; Li X; Zhang Z; Chen Y; Qiang S; Cheng H; Fan L; Liang P; Zhang J
Diagn Mol Pathol; 2012 Sep; 21(3):138-42. PubMed ID: 22847157
[TBL] [Abstract][Full Text] [Related]
5. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
[TBL] [Abstract][Full Text] [Related]
6. An improved fluorescence polarization assay in 5'-nuclease reaction for gene promoter methylation detection.
Su H; Wu Z; Wang Y; Jiang Y; Qiang S; Cheng H; Liu W; Zhang J
J Biotechnol; 2015 Oct; 211():81-6. PubMed ID: 26197420
[TBL] [Abstract][Full Text] [Related]
7. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.
Mikeska T; Bock C; El-Maarri O; Hübner A; Ehrentraut D; Schramm J; Felsberg J; Kahl P; Büttner R; Pietsch T; Waha A
J Mol Diagn; 2007 Jul; 9(3):368-81. PubMed ID: 17591937
[TBL] [Abstract][Full Text] [Related]
8. [Research on promoter region methylation status of tumor repressor gene P16 in human hepatocellular carcinoma by using methylation sensitive restriction enzyme and semi-nested PCR assay].
Jiang L; Qin Y; Sun ZL; Sun ZF; Wang JH; Yang LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):53-6. PubMed ID: 17294727
[TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric GP5+/6+ PCR and hybridization with fluorescence polarization assay of 15 human papillomavirus genotypes in clinical samples.
Ju Z; Yane G; Ding L; Guowu Y; Yanhai G; Yonglan L
J Clin Virol; 2009 Feb; 44(2):106-10. PubMed ID: 19144564
[TBL] [Abstract][Full Text] [Related]
11. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.
Reesink-Peters N; Wisman GB; Jéronimo C; Tokumaru CY; Cohen Y; Dong SM; Klip HG; Buikema HJ; Suurmeijer AJ; Hollema H; Boezen HM; Sidransky D; van der Zee AG
Mol Cancer Res; 2004 May; 2(5):289-95. PubMed ID: 15192122
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
[TBL] [Abstract][Full Text] [Related]
13. Detection of ERCC1 118 polymorphisms in non-small-cell lung cancer by an improved fluorescence polarization assay.
Wenchao L; Xiaohui L; Yan X; Helong Z; Wenzhao Y; Yanhai G; Zhen Y; Ju Z
Diagn Mol Pathol; 2010 Sep; 19(3):164-8. PubMed ID: 20736746
[TBL] [Abstract][Full Text] [Related]
14. IGSF4 promoter methylation and expression silencing in human cervical cancer.
Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma.
Luczak MW; Roszak A; Pawlik P; Kędzia H; Kędzia W; Malkowska-Walczak B; Lianeri M; Jagodziński PP
Int J Oncol; 2012 Mar; 40(3):860-6. PubMed ID: 21887463
[TBL] [Abstract][Full Text] [Related]
16. Detection and genotyping of human papillomavirus DNA in cervical cancer tissues with fluorescence polarization.
Gao YE; Zhang J; Wu J; Chen ZC; Yan XJ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):1029-34. PubMed ID: 14614542
[TBL] [Abstract][Full Text] [Related]
17. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J
Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736
[TBL] [Abstract][Full Text] [Related]
18. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.
Jung S; Yi L; Jeong D; Kim J; An S; Oh TJ; Kim CH; Kim CJ; Yang Y; Kim KI; Lim JS; Lee MS
Oncol Rep; 2011 Jan; 25(1):245-52. PubMed ID: 21109983
[TBL] [Abstract][Full Text] [Related]
19. Bisulfite-modified target DNA array for aberrant methylation analysis.
Zhou D; Qiao W; Yang L; Lu Z
Anal Biochem; 2006 Apr; 351(1):26-35. PubMed ID: 16516134
[TBL] [Abstract][Full Text] [Related]
20. Detection of primary YMDD mutations in HBV-related hepatocellular carcinoma using hybridization-fluorescence polarization.
Li D; Cheng H; Gong W; Jiang Y; Liang P; Zhang J
J Virol Methods; 2013 Feb; 187(2):259-63. PubMed ID: 23178585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
